Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia

Details for Australian Patent Application No. 2012201118 (hide)

Owner The Charlotte-Mecklenburg Hospital Authority

Inventors Kline, Jeffrey A.; Hernandez, Jackeline; Watts Jr., John Albert

Agent Watermark

Pub. Number AU-A-2012201118

Parent 2005262701

Filing date 27 February 2012

Wipo publication date 15 March 2012

International Classifications

A61B 5/08 (2006.01) Measuring for diagnostic purposes - Measuring devices for evaluating the respiratory organs

A61B 5/097 (2006.01) Measuring for diagnostic purposes

C12Q 1/04 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Determining presence or kind of micro-organism

G01N 33/579 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving limulus lysate

Event Publications

15 March 2012 Application Open to Public Inspection

  Published as AU-A-2012201118

15 March 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201119-Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia

2012201117-Utilizing lipopolysaccharide in exhaled breath condensate to diagnose gram negative pneumonia